Conventional and marked BHV-1 vaccines in Germany: A brief review;Konventionelle und markierte BHV-1-impfstoffe in Deutschland: Eine kurze übersicht

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 116, Issue 5-6, 2003, Pages 208-215

  Trapp, Sascha ^a   König, Patricia ^a   Beer, Martin ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

BHV 1; DIVA vaccine; Efficacy; Marker vaccine; Safety; Vaccine

Indexed keywords

VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; CATTLE; CATTLE DISEASE; COMPARATIVE STUDY; DRUG DESIGN; GERMANY; HERPES VIRUS INFECTION; IMMUNOLOGY; REPRODUCIBILITY; REVIEW; VIROLOGY;

ANIMALS; CATTLE; CATTLE DISEASES; DRUG DESIGN; GERMANY; HERPESVIRIDAE INFECTIONS; REPRODUCIBILITY OF RESULTS; VIRAL VACCINES;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE HERPESVIRUS 1; HERPESVIRIDAE;

EID: 0038029651     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Belknap, E. B., Walters, L. M., Kelling, C., Ayers, V. K., Norris, J., McMillen, J., Hayhow, C., Cochran, M., Reddy, D. N., Wright, J., Collins, J. K. (1999): Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine. Vaccine 17, 2297-2305.
2. Bosch, J. C., Kaashoek, M. J., Kroese, A. H., Van Oirschot, J. T. (1996): An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Vet. Microbiol. 52, 223-234.
3. Bosch, J. C., Kaashoek, M. J., Van Oirschot, J. T. (1997): Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine. Vaccine 15, 1512-1517.
4. Bryan, L. A., Fenton, R. A., Misra, V., Haines, D. M. (1994): Fatal, generalized bovine herpesvirus type-1 infection associated with a modified-live infectious bovine rhinotracheitis parainfluenza-3 vaccine administered to neonatal calves. Can. Vet. J. 35, 223-228.
5. Castrucci, G., Frigeri, F., Salvatori, D., Ferrari, M., Sardonini, Q., Cassai, E., Lo, D. M., Rotola, A., Angelini, R. (2002): Vaccination of calves against bovine herpesvirus-1: assessment of the protective value of eight vaccines. Comp Immunol. Microbiol. Infect. Dis. 25, 29-41.
6. Falcone, E., Tollis, M., Conti, G. (1999): Bovine viral diarrhea disease associated with a contaminated vaccine. Vaccine 18, 387-388.
7. Frerichs, G. N., Woods, S. B., Lucas, M. H. und Sands, J. J. (1982): Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines. Vet. Rec. 111, 116-122.
8. Gibbs, E. P. J., Rweyemamu, M. M. (1977): Bovine Herpesviruses. Part I. Bovine Herpesvirus 1. Veterinary Bulletin 47, 317-343.
9. Gogev, S., Vanderheijden, N., Lemaire, M., Schynts, F., D'Offay, J., Deprez, I., Adam, M., Eloit, M., Thiry, E. (2002): Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adeovirus-type 5 expressing glycoprotein gC or gD. Vaccine 20, 1451-1465.
10. Kaashoek, M. J., Moerman, A., Madic, J., Rijsewijk, F. A., Quak, J., Gielkens, A. L., Van Oirschot, J. T. (1994): A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12, 439-444.
11. Kaashoek, M. J., Van Oirschot, J. T. (1996): Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine. Vet. Microbiol. 53, 191-197.
12. Kendrick, J. W., York, C. J., McKercher, D. G. (1956): A controlled field trial of a vaccine for infectious bovine rhinotracheitis. Proc. U.S. Livestock San. Assoc. 60, 155-158.
13. König, P., Beer, M., Makoschey, B., Teifke, J.-P., Polster, U., Giesow, K., Keil, G. M. (2003): Evaluation of the immunmodulatory potential of virus-expressed bovine cytokines on the efficacy of a bovine herpesvirus 1 marker vaccine, submitted.
14. Kretzschmar, C. (1983): [Eradicability of infectious bovine rhinotracheitis (IBR)/infectious pustular vulvovaginitis (IPV) virus infection. 2. Studies of the virus latency of Riems IBR/IPV vaccine (live viral vaccine) virus strain and field virus following infection of immunized animals]. Arch. Exp. Veterinarmed. 37, 829-835.
15. Lazarowicz, M., Steck, F., Ackermann, M., Kihm, U. (1983): Testing of 2 vaccines against infectious bovine rhinotracheitis. Schweiz. Arch. Tierheilkd. 125, 797-808.
16. Loehr, B. I., Willson, P., Babiuk, L. A., Van Drunen Littel-Van Den Hurk. (2000): Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle. J. Virol. 74, 6077-6086.
17. Madin, S. H., York, C. J., McKercher, D. G. (1956): Isolation of infectious bovine rhinotracheitis virus 447. Science 124, 721-722.
18. Mahony, T. J., McCarthy, F. M., Gravel, J. L., West, L., Young, P. L. (2002): Construction and Manipulation of an Infectious Clone of the Bovine Herpesvirus 1 Genome Maintained as a Bacterial Artificial Chromosome. J. Virol. 76, 6660-6668.
19. Makoschey, B., Keil, G. M. (2000): Early immunity induced by a glycoprotein E-negative vaccine for infectious bovine rhinotracheitis. Vet. Rec. 147, 189-191.
20. Mars, M. H. (2000): Efficacy of two live combination vaccines against bovine respiratory syncytial virus (BRSV) and bovine herpesvirus 1 (BHV1) challenge infections in calves. Vaccinology and epidemiology of bovine herpesvirus 1 infections PHD Thesis, University Utrecht.
21. Mars, M. H., de Jong, M. C., Franken, P., Van Oirschot, J. T. (2001): Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field. Vaccine 19, 1924-1930.
22. Mars, M. H., de Jong, M. C., Van Oirschot, J. T. (2000a): A gE-negative BHV1 vaccine virus strain cannot perpetuate in cattle populations. Vaccine 18, 2120-2124.
23. Mars, M. H., de Jong, M. C., Van Oirschot, J. T. (2000b): A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments. Vaccine 18, 1975-1981.
24. Meyer, H., Mayr , A., Bachmann, P. A., Bernadi, G., Wagner, H. (1985): Schutzimpfung von latent IBR-IPV-Virus infizierten Bullen mit einer Vakzine aus inaktiviertem IBR-Virus. Tierärztl. Umschau 40, 974-985.
25. Pastoret, P. P., Babiuk, L. A., Misra, V, Griebel, P. (1980): Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone. Infect. Immun. 29, 483-488.
26. Patel, J. R., Makoschey, B., Kaashoek, M. J., van Gelder, P. T. J. A. (2002): A new infectious bovine rhinotracheitis (IBR) marker vaccine provides early immunity and is produced in serum-free cell substrate. Abstracts, XXII World Buiatrics Congress 2002, 18-23 August, Hannover, Germany.
27. Rebordosa, X., Pinol, J., Perez-Pons, J. A., Lloberas, J., Naval, J., Serra-Hartmann, X., Espuna, E., Querol, E. (1996): Glycoprotein E of bovine herpesvirus type 1 is involved in virus transmission by direct cell-to-cell spread. Virus Res. 45, 59-68.
28. Rijsewijk, F. A., Kaashoek, M. J., Madic, J., Paal, H., Ruuls, R. C., Gielkens, A., Van Oirschot, J. T. (1993): Characterization of a DNA rearrangement found in the unique short region of the Za strain of bovine herpesvirus type 1 and the vaccine properties of this strain. Proc. 18th Int. Herpesvirus Workshop, Pittsburgh, July 25-30 p. C-67
29. Savan, M., Angulo, A. B., Derbyshire, J. B. (1979): Interferon, antibody responses and protection induced by an intranasal infectious bovine rhinotracheitis vaccine. Can. Vet. J. 20, 207-210.
30. Sutton, M. L. (1980): Rapid onset of immunity in cattle after intramuscular injection of a modified-live-virus IBR vaccine. Vet. Med. Small Anim. Clin. 75, 1447-1456.
31. Thiry, E., Saliki, J., Bublot, M., Pastoret, P. P. (1987): Reactivation of infectious bovine rhinotracheitis virus by transport. Comp Immunol. Microbiol. Infect. Dis. 10, 59-63.
32. Trapp, S., Osterrieder, N., Keil, G., Beer, M. (2003): Mutagenesis of a bovine herpesvirus type 1 genome cloned as an infectious bacterial artificial chromosome: analysis of glycoprotein E and G double deletion mutants. J. Gen. Virol., in press.
33. Van der Poel, W. H., Hage, J. J. (1998): [Spread of an intramuscularly administered live gE-negative BHV1 marker vaccine in 2 cattle farms]. Tijdschr. Diergeneeskd. 123, 109-111.
34. Van Drunen Littel-Van Den Hurk, Braun, R. P., Lewis, P. J., Karvonen, B. C., Baca-Estrada, M. E., Snider, M., McCartney, D., Watts, T., Babiuk, L. A. (1998): Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J. Gen. Virol. 79, 831-839.
35. Van Drunen Littel-Van Den Hurk, Parker, M. D., Massie, B., van den Hurk, J. V., Harland, R., Babiuk, L. A., Zamb, T. J. (1993): Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 11, 25-35.
36. Van Oirschot, J. T. (1999): Diva vaccines that reduce virus transmission. J. Biotechnol. 73, 195-205.
37. Van Oirschot, J. T., Kaashoek, M. J., Maris-Veldhuis, M. A., Weerdmeester, K., Rijsewijk, F. A. (1997): An enzyme-linked immunosorbent assay to detect ahtibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle. J. Virol. Methods 67, 23-34.
38. Van Oirschot, J. T., Kaashoek, M. J., Rijsewijk, F. A., Stegeman, J. A. (1996): The use of marker vaccines in eradication of herpesviruses. J. Biotechnol. 44, 75-81.
39. Wagner, M., Ruzsics, Z. Koszinowski, U. H. (2002): Herpesvirus genetics has come of age. Trends Microbiol. 10, 318-324.
40. Wentzel, E. (1996): Untersuchungen zur Latenz und Reaktivierbarkeit einer natürlichen BHV-1-Mutante mit einer gE-Deletion. Inaugural Dissertation, Universität München
41. Whetstone, C. A., Wheeler, J. G. Reed, D. E. (1986): Investigation of possible vaccine-induced epizootics of infectious bovine rhinotracheitis, using restriction endonuclease analysis of viral DNA. Am. J. Vet. Res. 47, 1789-1795.